Horizon Discovery completes £68.6m IPO
Horizon Discovery Group, a UK biotech firm, will launch on London’s AIM with a market capitalisation of £120m later this week after completing a £68.6m IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: